|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics. CA Cancer J Clin.
58:71–96. 2008.
|
|
2
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 2:293–308. 2009.
|
|
3
|
Mahooti S, Porter K, Alpaugh ML, et al:
Breast carcinomatous tumoral emboli can result from encircling
lymphovasculogenesis rather than lymphovascular invasion.
Oncotarget. 2:131–147. 2010.PubMed/NCBI
|
|
4
|
Conboy J, Kan YW, Shohet SB and Mohandas
N: Molecular cloning of protein 4.1, a major structural element of
the human erythrocyte membrane skeleton. Proc Natl Acad Sci USA.
83:9512–9516. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parra M, Gascard P, Walensky LD, et al:
Molecular and functional characterization of protein 4.1B, a novel
member of the protein 4.1 family with high level, focal expression
in brain. J Biol Chem. 275:3247–3255. 2000. View Article : Google Scholar
|
|
6
|
Parra M, Gascard P, Walensky LD, Snyder
SH, Mohandas N and Conboy JG: Cloning and characterization of 4.1G
(EPB41L2), a new member of the skeletal protein 4.1 (EPB41) gene
family. Genomics. 49:298–306. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walensky LD, Blackshaw S, Liao D, et al: A
novel neuron-enriched homolog of the erythrocyte membrane
cytoskeletal protein 4.1. J Neurosci. 19:6457–6467. 1999.PubMed/NCBI
|
|
8
|
Chishti AH, Kim AC, Marfatia SM, et al:
The FERM domain: a unique module involved in the linkage of
cytoplasmic proteins to the membrane. Trends Biochem Sci.
23:281–282. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pearson MA, Reczek D, Bretscher A and
Karplus PA: Structure of the ERM protein moesin reveals the FERM
domain fold masked by an extended actin binding tail domain. Cell.
101:259–270. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han BG, Nunomura W, Takakuwa Y, Mohandas N
and Jap BK: Protein 4.1R core domain structure and insights into
regulation of cytoskeletal organization. Nat Struct Biol.
7:871–875. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diakowski W, Grzybek M and Sikorski AF:
Protein 4.1, a component of the erythrocyte membrane skeleton and
its related homologue proteins forming the protein 4.1/FERM
superfamily. Folia Histochem Cytobiol. 44:231–248. 2006.PubMed/NCBI
|
|
12
|
Ohtani K, Sakamoto H, Rutherford T, Chen
Z, Satoh K and Naftolin F: Ezrin, a membrane-cytoskeletal linking
protein, is involved in the process of invasion of endometrial
cancer cells. Cancer Lett. 147:31–38. 1999. View Article : Google Scholar
|
|
13
|
Khanna C, Wan X, Bose S, et al: The
membrane-cytoskeleton linker ezrin is necessary for osteosarcoma
metastasis. Nat Med. 10:182–186. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tran YK, Bögler O, Gorse KM, Wieland I,
Green MR and Newsham IF: A novel member of the NF2/ERM/4.1
superfamily with growth suppressing properties in lung cancer.
Cancer Res. 59:35–43. 1999.PubMed/NCBI
|
|
15
|
Gutmann DH, Donahoe J, Perry A, et al:
Loss of DAL-1, a protein 4.1-related tumor suppressor, is an
important early event in the pathogenesis of meningiomas. Hum Mol
Genet. 10:1495–1500. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Robb VA, Li W, Gascard P, Perry A,
Mohandas N and Gutmann DH: Identification of a third Protein 4.1
tumor suppressor, Protein 4.1R, in meningioma pathogenesis.
Neurobiol Dis. 13:191–202. 2003. View Article : Google Scholar
|
|
17
|
Cavanna T, Pokorná E, Veselý P, Gray C and
Zicha D: Evidence for protein 4.1B acting as a metastasis
suppressor. J Cell Sci. 120:606–616. 2007. View Article : Google Scholar
|
|
18
|
Sun CX, Robb VA and Gutmann DH: Protein
4.1 tumor suppressors: getting a FERM grip on growth regulation. J
Cell Sci. 115:3991–4000. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kittiniyom K, Gorse KM, Dalbegue F, Lichy
JH, Taubenberger JK and Newsham IF: Allelic loss on chromosome band
18p11.3 occurs early and reveals heterogeneity in breast cancer
progression. Breast Cancer Res. 3:192–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ohno N, Terada N, Murata S, et al:
Immunolocalization of protein 4.1B/DAL-1 during neoplastic
transformation of mouse and human intestinal epithelium. Histochem
Cell Biol. 122:579–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Terada N, Ohno N, Yamakawa H, et al:
Protein 4.1B in mouse islets of Langerhans and beta-cell
tumorigenesis. Histochem Cell Biol. 120:277–283. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Charboneau AL, Singh V, Yu T and Newsham
IF: Suppression of growth and increased cellular attachment after
expression of DAL-1 in MCF-7 breast cancer cells. Int J Cancer.
100:181–188. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye K, Compton DA, Lai MM, Walensky LD and
Snyder SH: Protein 4.1N binding to nuclear mitotic apparatus
protein in PC12 cells mediates the antiproliferative actions of
nerve growth factor. J Neurosci. 19:10747–10756. 1999.PubMed/NCBI
|
|
24
|
Zhou Y, Du G, Hu X, et al: Nectin-like
molecule 1 is a protein 4.1N associated protein and recruits
protein 4.1N from cytoplasm to the plasma membrane. Biochim Biophys
Acta. 1669:142–154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen L, Liang F, Walensky LD and Huganir
RL: Regulation of AMPA receptor GluR1 subunit surface expression by
a 4.1N-linked actin cytoskeletal association. J Neurosci.
20:7932–7940. 2000.PubMed/NCBI
|
|
26
|
Binda AV, Kabbani N, Lin R and Levenson R:
D2 and D3 dopamine receptor cell surface localization mediated by
interaction with protein 4.1N. Mol Pharmacol. 62:507–513. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maximov A, Tang TS and Bezprozvanny I:
Association of the type 1 inositol (1,4,5)-trisphosphate receptor
with 4.1N protein in neurons. Mol Cell Neurosci. 22:271–283. 2003.
View Article : Google Scholar
|
|
28
|
Heller G, Geradts J, Ziegler B, et al:
Downregulation of TSLC1 and DAL-1 expression occurs frequently in
breast cancer. Breast Cancer Res Treat. 3:283–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gutmann DH, Hirbe AC, Huang ZY and Haipek
CA: The protein 4.1 tumor suppressor, DAL-1, impairs cell motility,
but regulates proliferation in a cell-type-specific fashion.
Neurobiol Dis. 8:266–278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gutmann DH, Sherman L, Seftor L, Haipek C,
Hoang Lu K and Hendrix M: Increased expression of the NF2 tumor
suppressor gene product, merlin, impairs cell motility, adhesion
and spreading. Hum Mol Genet. 8:267–275. 1999. View Article : Google Scholar : PubMed/NCBI
|
